Clinical Trials Browser

Interventional × Diarrhea × 1 year × Clear all

NCT00093353 2026-04-14

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Phase 1 Completed

Diarrhea, Neuroblastoma, Drug-Related Side Effects and Adverse Reactions

NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Phase 1 Recruiting

BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

NCT07426822 2026-02-24

SAFE-CAP

Phase 2 Not yet recruiting

Diarrhea, Exanthema

NCT06801067 2025-12-02

A Study of SER-155 to Treat Diarrhea in People on Immunotherapy

Phase 1 Recruiting

Diarrhea, Enterocolitis

NCT06206707 2025-11-17

Immunobiome

Phase NA Recruiting

DermatologicGenitourinary

Colitis, Diarrhea, Kidney Neoplasms, Melanoma

NCT03767257 2025-10-21

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

Phase 2 Completed

25 enrolled 6 charts

Diarrhea, Multiple Myeloma

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Phase 2 Completed

43 enrolled 23 charts

GastrointestinalOtherPlasma cell

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

NCT06892093 2025-09-08

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Phase NA Recruiting

Breast Neoplasms, Diarrhea